[Feasibility, efficacy and safety of transbrachial access for interventional therapy on paravalvular leak post surgical valve replacement] [0.03%]
经锁骨下途径封堵外科生物瓣瓣周漏的可行性、有效性和安全性
H Zhang,H B Hu,J H Lyu et al.
H Zhang et al.
Objective: To investigate the feasibility, efficacy and safety of transbrachial access for interventional therapy on prosthetic paravalvular leak (PVL) post surgical valve replacement. Methods: This is a retrospective study. Patients with P...
[Left ventricular guidewire pacing during transcatheter aortic valve replacement] [0.03%]
经导管主动脉瓣置换术中左心室导丝起搏
G Y Song,X M Liu,S Y Teng et al.
G Y Song et al.
Objective: To investigate the safety and efficacy of left ventricular guidewire pacing during transcatheter aortic valve replacement (TAVR). Methods: This is a retrospective study. Thirteen patients, who underwent TAVR with left ventricular...
[Safety and efficacy of transcatheter tricuspid valve replacement with LuX-Valve in patients with severe tricuspid regurgitation] [0.03%]
LuX-Valve经导管三尖瓣置换治疗严重三尖瓣反流的安全性和有效性
X P Ning,Z An,F Qiao et al.
X P Ning et al.
Objectives: To evaluate the safety and efficacy of LuX-Valve on the treatment of severe tricuspid regurgitation (TR). Methods: This is a prospective observational study. From September 2018 to March 2019, 12 patients with severe TR, who wer...
[Chinese Society of Cardiology and Chinese College of Cardiovascular Physicians Expert Consensus statement on dual antiplatelet therapy in patients with coronary artery disease] [0.03%]
中国冠心病患者双联抗血小板治疗专家共识
Atherosclerosis and Coronary Heart Disease Working Group of Chinese Society of Cardiology;Interventional Cardiology Working Group of Chinese Society of Cardiology;Specialty Committee on Prevention and Treatm
Atherosclerosis and Coronary Heart Disease Working Group of Chinese Society of Cardiology;Interventional Cardiology Working Group of Chinese Society of Cardiology;Specialty Committee on Prevention and Treatm
[Current status and progress of transcatheter mitral regurgitation interventional therapy] [0.03%]
[经导管介入治疗二尖瓣反流的现状与进展]
X P Lin,Q F Zhu,X B Liu et al.
X P Lin et al.
M Chen,Z C Jing,H Zhang et al.
M Chen et al.
[Mechanism, clinical manifestation and management of adverse cardiac reactions related to immune checkpoint inhibitors] [0.03%]
[免疫检查点抑制剂相关不良心脏反应的发生机制、临床表现及处理措施]
S F Jiang,C Dong,Y Liu et al.
S F Jiang et al.